Agios Pharmaceuticals Inc (AGIO)
30.28
-0.56
(-1.82%)
USD |
NASDAQ |
Mar 28, 16:00
30.32
+0.04
(+0.13%)
After-Hours: 20:00
Agios Pharmaceuticals Max Drawdown (5Y): 82.86% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 42.46% |
| Bruker Corp | 49.79% |
| Palatin Technologies Inc | 97.60% |
| Blueprint Medicines Corp | 69.50% |
| Organon & Co | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -21.10 |
| Beta (5Y) | 0.9031 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 52.20% |
| Historical Sharpe Ratio (5Y) | -0.1566 |
| Historical Sortino (5Y) | -0.2611 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.08% |